arrow
F

Francisco Bosques-Padilla

Tecnologico de Monterrey
H指数:30
被引数:4,244

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Fifth Mexican consensus on the diagnosis and treatment of Helicobacter pylori infection

第五届墨西哥关于幽门螺杆菌感染诊断与治疗的共识

2026-01-010
OAAI
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease

靶向抑制致病共生菌毒力因子可缓解酒精性肝病

2025-05-280
PRE
RISE-MX, a real-world study of patients with moderate/severe inflammatory bowel disease returning for hospital follow-up in Mexico: baseline demographics and clinical characteristics, treatment and disease status

RISE-MX,一项针对墨西哥中度/重度炎症性肠病患者的真实世界研究: 基线人口统计学和临床特征,治疗和疾病状况

2025-02-170
OAAI
Viral antibody response predicts morbidity and mortality in alcohol-associated hepatitis
2024-09-250
PRE
Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design
2024-08-010
OAAI
Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis
2024-02-201
PRE
Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH)
2022-03-0730
OAAI
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis
2022-02-0124
OAAI
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated Hepatitis
2021-07-317
PREAI
Intestinal Virome in Patients With Alcoholic Hepatitis

酒精性肝炎患者的肠道病毒

2020-10-1083
OAAI
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study
2020-08-1941
OAAI
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis

酒精性肝炎患者的肠道真菌生态失调和对真菌的全身免疫反应

2019-08-20176
OAAI